KEAP1 and colitis: The present study demonstratedthat SA has the ability to enhanceintestinal barrier integrity, inhibit the activation of the NLRP3inflammasome, reduce the amount of pro-inflammatory factors, and increasethe activity of antioxidant enzymes to alleviate colitis and is associatedwith the regulation of the Nrf2/Keap1 pathway.